Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521906 · ClinicalTrials.gov registry record · NA
Evaluation of PRYSHM for LGBTQIA2S+ Youth
A NA study of Alcohol Drinking and Dating Violence, sponsored by University of Nebraska Lincoln.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
- 1
- Study location
NCT05521906: Completed NA study of Alcohol Drinking and Dating Violence, sponsored by University of Nebraska Lincoln.
NCT05521906 is a NA study of Alcohol Drinking and Dating Violence that has completed, run by University of Nebraska Lincoln. The registered enrollment target is 314 participants, below the 627-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521906, a NA study of Alcohol Drinking and Dating Violence, has completed, sponsored by University of Nebraska Lincoln.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the proposed project is to develop an innovative, online synchronous DV and AU prevention curriculum created specifically for SGMY (ages 15 to 18); conduct a pilot randomized controlled trial to assess its feasibility and acceptability of the intervention and study procedures; identify preliminary outcomes of the intervention; and ensure that the intervention is working equally well for SGMY of color.
Primary Outcome
The Measure of Adolescent Relationship Harassment and Abuse (MARSHA): Perpetration Scale assesses how often an individual perpetrates dating violence. Participants rate how frequently they engaged in specific behaviors from 0 to 100 times over the past three months (at Week 21). The total score was created by summing the items. The range is 0 to 476. Higher scores represent more intimate partner violence perpetration.
Conditions Studied
Interventions
- BEHAVIORAL Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM)
Study Locations (1)
Nebraska
- University of Nebraska (Lincoln) - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2023-12-07 |
| Phase | NA |
What the finished NCT05521906 record still lists
NCT05521906 is an interventional study that assigns participants to a tested intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap, below the 627-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM) is the first listed.
NCT05521906 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT05521906 about?
NCT05521906 is a clinical study titled "Evaluation of PRYSHM for LGBTQIA2S+ Youth". The overarching goal of the proposed project is to develop an innovative, online synchronous DV and AU prevention curriculum created specifically for SGMY (ages 15 to 18); conduct a pilot randomized controlled trial to assess its feasibility and acceptability of the intervention and study procedures...
What is the current status of trial NCT05521906?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2022-09-21. Estimated completion is 2023-12-07.
What conditions does trial NCT05521906 study?
This clinical trial studies the following conditions: Alcohol Drinking, Dating Violence.
What interventions are being tested in trial NCT05521906?
The interventions under investigation include: Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05521906?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521906 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05521906's enrollment target sits among peer trials
314 32nd of 85 higher than 54 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
- NCT06883097 · 314 participants · NA
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI